Go to deals
Healthcare

Sedona Invest has acquired Abiocom

October 2021 — The shareholders of Abiocom have sold the company to Sedona Invest.

Sedona Invest is a family office founded in 2020 dedicated to the well-being and organic industries.

Founded in 2007, Abiocom is specialized in design, development and distribution of organic well-being products. The company provides a wide range of more than 300 products from seven own brands and two other brands in exclusive distribution, covering five categories: food supplements, cosmetics, make-up, incense and eco-housing. Abiocom has a portfolio of over 1,700 active clients, including organic chains and independent stores.

Our role in the transaction

Oaklins’ team in France acted as advisor to the shareholders of Sedona Invest in this transaction.

Parties

Talk to the deal team

Eric Félix-Faure

Managing Partner
Paris, France
Oaklins France

Antoine Lemaire

Partner
Paris, France
Oaklins France

Quentin Boissinot

Associate Director
Paris, France
Oaklins France

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more